Download PDF
1 / Pages

Other users also viewed these articles

Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis Alejandro Balsa; Petra Díaz del Campo Fontecha; Lucía Silva Fernández; José Valencia Martín; Virginia Nistal Martínez; Fernando León Vázquez; M. Vanesa Hernández Hernández; Héctor Corominas; Rafael Cáliz Cáliz; José María Aguado García; Gloria Candelas Rodríguez; Nora Ibargoyen Roteta; Arturo Martí Carvajal; M. Nieves Plana Farras; Janet Puñal Riobóo; Hye Sang Park; Yolanda Triñanes Pego; Virginia Villaverde García;
Reumatol Clin. 2023;19:533-48
Fibromyalgia with elevated rheumatoid factor is associated with poor therapeutic response but not with progression to rheumatoid arthritis. Prospective cohort study Freddy Liñán Ponce; Juan Leiva Goicochea; David Sevilla Rodríguez; Elmer Hidalgo Bravo; Ginna Obregón Atanacio; Inés Loyola Macalapú; Paola Jáuregui Rojas; Jackeline Yampufe Canani;
10.1016/j.reumae.2024.10.001
Gastrointestinal symptoms in patients using methotrexate: A cross-sectional study in a sample with rheumatoid arthritis Carina Albuquerque Roberto; Isabela Stachevski; Barbara Stadler Kahlow; Renato Nisihara; Thelma Skare;
Reumatol Clin. 2024;20:403-8